ENTERA BIO LTD (ENTX) Stock Analyst Earnings Estimates
NASDAQ:ENTX - Nasdaq - IL0011429839 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 370K 54.17% | 570K 54.05% | 130K -77.19% | -100.00% | 141.78K | -100.00% | |
| EBITDA YoY % growth | -11.11M 0.89% | -12.17M -9.54% | -12.96M -6.49% | N/A 31.83% | N/A | N/A | |
| EBIT YoY % growth | -11.17M 2.45% | -12.22M -9.40% | -13.02M -6.55% | -9.821M 31.71% | -10.81M -21.58% | -28.968M -167.98% | |
| Operating Margin | -3,018.92% | -2,143.86% | -10,015.38% | N/A | -7,624.46% | N/A | |
| EPS YoY % growth | N/A | -0.62 -8.54% | -0.45 27.42% | -0.33 31.11% | -0.29 7.87% | -0.56 -96.43% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 -16.57% | -0.07 -42.80% | -0.11 -87.00% | -0.16 -104.00% | -0.20 -150.00% |
| Revenue Q2Q % growth | 40.8K | -100.00% | -100.00% | -100.00% | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.417M -74.07% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.08 | -0.05 | -0.03 | -56.86% |
| Q2 2024 Q2Q % growth | -0.06 25.00% | -0.06 | 0.00 | 1.96% |
| Q1 2024 Q2Q % growth | -0.05 37.50% | -0.06 | 0.01 | 18.30% |
| Q4 2023 Q2Q % growth | -0.07 30.00% | -0.08 | 0.01 | 14.22% |
| Q3 2023 Q2Q % growth | -0.08 27.27% | -0.09 | 0.01 | 12.85% |
| Q2 2023 Q2Q % growth | -0.08 27.27% | -0.07 | -0.01 | -12.04% |
| Q1 2023 Q2Q % growth | -0.08 38.46% | -0.12 | 0.04 | 34.64% |
| Q4 2022 Q2Q % growth | -0.10 52.38% | -0.12 | 0.02 | 14.75% |
| Q3 2022 Q2Q % growth | -0.11 -22.22% | -0.14 | 0.03 | 20.12% |
| Q2 2022 Q2Q % growth | -0.11 47.62% | -0.16 | 0.05 | 32.60% |
| Q1 2022 Q2Q % growth | -0.13 -18.18% | -0.18 | 0.05 | 27.86% |
| Q4 2021 Q2Q % growth | -0.21 -61.54% | -0.24 | 0.03 | 11.76% |
| Q3 2021 Q2Q % growth | -0.09 | -0.12 | 0.03 | 23.27% |
| Q2 2021 Q2Q % growth | -0.21 -23.53% | -0.12 | -0.09 | -71.57% |
| Q1 2021 Q2Q % growth | -0.11 | -0.12 | 0.01 | 10.13% |
| Q4 2020 Q2Q % growth | -0.13 | -0.14 | 0.01 | 8.96% |
| Q3 2020 Q2Q % growth | -0.09 64.00% | -0.20 | 0.11 | 55.88% |
| Q2 2020 Q2Q % growth | -0.17 -41.67% | -0.12 | -0.05 | -38.89% |
| Q3 2019 Q2Q % growth | -0.25 | -0.15 | -0.10 | -63.40% |
| Q2 2019 Q2Q % growth | -0.12 | -0.29 | 0.17 | 57.98% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 42K | 40.8K | 1.2K | 2.94% |
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q3 2023 Q2Q % growth | -100.00% | % | ||
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | -100.00% | 102K | -102K | -100.00% |
| Q4 2022 Q2Q % growth | 10K -94.12% | 51K | -41K | -80.39% |
| Q3 2022 Q2Q % growth | 10K -92.86% | 71.4K | -61.4K | -85.99% |
| Q2 2022 Q2Q % growth | 40K -63.64% | 68.003K | -28.003K | -41.18% |
| Q1 2022 Q2Q % growth | 70K -56.25% | 182.07K | -112.07K | -61.55% |
| Q4 2021 Q2Q % growth | 170K -22.73% | 129.54K | 40.46K | 31.23% |
| Q3 2021 Q2Q % growth | 140K 180.00% | 61.2K | 78.8K | 128.76% |
| Q2 2021 Q2Q % growth | 110K 120.00% | 88.23K | 21.77K | 24.67% |
| Q1 2021 Q2Q % growth | 160K 300.00% | 92.82K | 67.18K | 72.38% |
| Q4 2020 Q2Q % growth | 220K 120.00% | 220K | % | |
| Q3 2020 Q2Q % growth | 50K -16.67% | 50K | % | |
| Q2 2020 Q2Q % growth | 50K -28.57% | 50K | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |